Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen C Steel

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Translational Oncology|March 7, 2022
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinomaNonkululeko Z Malinga, Shalete C Siwele, Helen C Steel, et al.
International Journal of Molecular Sciences|December 11, 2025
A Pilot Study on the Potential Pathological Link Between Oxidative Stress Markers and Renal Function in People Living with HIVJoel Choshi, Haskly Mokoena, Helen C Steel, et al.
Molecules (Basel, Switzerland)|December 23, 2022
Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro StudyAnnette J Theron, Ronald Anderson, Morris Madzime, et al.
Frontiers in Oncology|April 17, 2023
Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3Bernardo L Rapoport, Helen C Steel, Carol A Benn, et al.
Clinical Immunology (Orlando, Fla.)|July 19, 2024
Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South AfricaMieke A van der Mescht, Zelda de Beer, Helen C Steel, et al.
Frontiers in Immunology|June 9, 2022
Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint MoleculesBernardo L Rapoport, Helen C Steel, Nomsa Hlatshwayo, et al.
The Journal of Infectious Diseases|May 16, 2019
Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral TherapyStefanie Kroeze, Ferdinand W Wit, Theresa M Rossouw, et al.
The Journal of Infectious Diseases|December 29, 2020
Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral TherapyStefanie Kroeze, Theresa M Rossouw, Helen C Steel, et al.
The Journal of Infection|January 9, 2026
Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV diseaseRofhiwa Nesamar, Carol Crowther, Dexter T Chiveto, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Translational Oncology|March 7, 2022
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinomaNonkululeko Z Malinga, Shalete C Siwele, Helen C Steel, et al.
International Journal of Molecular Sciences|December 11, 2025
A Pilot Study on the Potential Pathological Link Between Oxidative Stress Markers and Renal Function in People Living with HIVJoel Choshi, Haskly Mokoena, Helen C Steel, et al.
Molecules (Basel, Switzerland)|December 23, 2022
Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro StudyAnnette J Theron, Ronald Anderson, Morris Madzime, et al.
Frontiers in Oncology|April 17, 2023
Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3Bernardo L Rapoport, Helen C Steel, Carol A Benn, et al.
Clinical Immunology (Orlando, Fla.)|July 19, 2024
Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South AfricaMieke A van der Mescht, Zelda de Beer, Helen C Steel, et al.
Frontiers in Immunology|June 9, 2022
Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint MoleculesBernardo L Rapoport, Helen C Steel, Nomsa Hlatshwayo, et al.
The Journal of Infectious Diseases|May 16, 2019
Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral TherapyStefanie Kroeze, Ferdinand W Wit, Theresa M Rossouw, et al.
The Journal of Infectious Diseases|December 29, 2020
Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral TherapyStefanie Kroeze, Theresa M Rossouw, Helen C Steel, et al.
The Journal of Infection|January 9, 2026
Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV diseaseRofhiwa Nesamar, Carol Crowther, Dexter T Chiveto, et al.
Pageof 6